106 related articles for article (PubMed ID: 14656702)
21. Coexpression studies with endothelin receptor subtypes indicate the existence of intracellular cross-talk between ET(A) and ET(B) receptors.
Ozaki S; Ohwaki K; Ihara M; Ishikawa K; Yano M
J Biochem; 1997 Mar; 121(3):440-7. PubMed ID: 9133612
[TBL] [Abstract][Full Text] [Related]
22. Stimulatory action of endothelin-1 on rat Leydig cells: involvement of endothelin-A subtype receptor and phospholipase A2-arachidonate metabolism system.
Romanelli F; Fillo S; Isidori A; Conte D
Life Sci; 1997; 61(5):557-66. PubMed ID: 9247325
[TBL] [Abstract][Full Text] [Related]
23. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
Allcock GH; Warner TD; Vane JR
Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
[TBL] [Abstract][Full Text] [Related]
24. Endothelin ET(A) but not ET(B) receptors mediate contraction of common bile duct.
Huang SC
Regul Pept; 2003 May; 113(1-3):131-8. PubMed ID: 12686472
[TBL] [Abstract][Full Text] [Related]
25. Endothelin-1 activates ETA receptors to cause reflex scratching in BALB/c mice.
McQueen DS; Noble MA; Bond SM
Br J Pharmacol; 2007 May; 151(2):278-84. PubMed ID: 17351652
[TBL] [Abstract][Full Text] [Related]
26. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
Warner TD; Allcock GH; Corder R; Vane JR
Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
[TBL] [Abstract][Full Text] [Related]
27. Distribution of endothelin-1-receptor subtypes in rat portal vein.
Filippelli A; Falciani M; Palla A; D'Amico M; Vacca C; Rossi F
J Cardiovasc Pharmacol; 1996 Jan; 27(1):113-18. PubMed ID: 8656643
[TBL] [Abstract][Full Text] [Related]
28. Regional modulation of cyclic nucleotides by endothelin-1 in rat pulmonary arteries: direct activation of G(i)2-protein in the main pulmonary artery.
Mullaney I; Vaughan DM; MacLean MR
Br J Pharmacol; 2000 Mar; 129(5):1042-8. PubMed ID: 10696107
[TBL] [Abstract][Full Text] [Related]
29. Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and alpha1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes.
Bender SB; Klabunde RE
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2281-8. PubMed ID: 17660396
[TBL] [Abstract][Full Text] [Related]
30. Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery.
Fukuroda T; Ozaki S; Ihara M; Ishikawa K; Yano M; Nishikibe M
Br J Pharmacol; 1994 Oct; 113(2):336-8. PubMed ID: 7834180
[TBL] [Abstract][Full Text] [Related]
31. Endothelin-1[1-31], acting as an ETA-receptor selective agonist, stimulates proliferation of cultured rat zona glomerulosa cells.
Mazzocchi G; Rossi GP; Malendowicz LK; Champion HC; Nussdorfer GG
FEBS Lett; 2000 Dec; 487(2):194-8. PubMed ID: 11150508
[TBL] [Abstract][Full Text] [Related]
32. Endothelin-1, acting via the A receptor subtype, stimulates thymocyte proliferation in the rat.
Malendowicz LK; Brelinska R; De Caro R; Trejer M; Nussdorfer GG
Life Sci; 1998; 62(21):1959-63. PubMed ID: 9619845
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms transducing the aldosterone secretagogue signal of endothelins in the human adrenal cortex.
Andreis PG; Neri G; Tortorella C; Aragona F; Rossi GP; Nussdorfer GG
Peptides; 2002 Mar; 23(3):561-6. PubMed ID: 11836007
[TBL] [Abstract][Full Text] [Related]
34. Evidence that both ETA and ETB receptor subtypes are involved in the in vivo aldosterone secretagogue effect of endothelin-1 in rats.
Mazzocchi G; Rebuffat P; Gottardo G; Meneghelli V; Nussdorfer GG
Res Exp Med (Berl); 1996; 196(3):145-52. PubMed ID: 8875700
[TBL] [Abstract][Full Text] [Related]
35. Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries.
Compeer MG; Janssen GM; De Mey JG
Br J Pharmacol; 2013 Nov; 170(6):1199-209. PubMed ID: 23941276
[TBL] [Abstract][Full Text] [Related]
36. Nuclear Ca2+ signaling to endothelin-1 in rat aortic smooth-muscle cells.
Naik RD; McNeill JR; Wilson TW; Gopalakrishnan V
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S199-202. PubMed ID: 9595437
[TBL] [Abstract][Full Text] [Related]
37. Hyperresponsiveness to ET-1 after treatment with a mixture of ETA and ETB receptor antagonists in the rabbit in vivo and in vitro.
D'Orléans-Juste P; Yano M; Maurice MC; Gratton JP
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S369-72. PubMed ID: 8587417
[TBL] [Abstract][Full Text] [Related]
38. Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists.
Hay DW; Luttmann MA
J Pharmacol Exp Ther; 1997 Feb; 280(2):959-65. PubMed ID: 9023312
[TBL] [Abstract][Full Text] [Related]
39. Role of endothelin receptors on basal and endothelin-1-stimulated lung myofibroblast proliferation.
Préfontaine A; Calderone A; Dupuis J
Can J Physiol Pharmacol; 2008 Jun; 86(6):337-42. PubMed ID: 18516096
[TBL] [Abstract][Full Text] [Related]
40. Endothelin generating pathway through endothelin1-31 in human cultured bronchial smooth muscle cells.
Hayasaki-Kajiwara Y; Naya N; Shimamura T; Iwasaki T; Nakajima M
Br J Pharmacol; 1999 Jul; 127(6):1415-21. PubMed ID: 10455291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
